Home > Financial Ratios > KREBS BIOCHEMICALS & INDUSTRIES

KREBS BIOCHEMICALS & INDUSTRIES
Core EBITDA Margin

    Back to All Ratios
COMMUNITY POLL
for KREBS BIOCHEMICALS & INDUSTRIES
Please provide your vote to see the results

KREBS BIOCHEMICALS & INDUSTRIES Last 5 Year Core EBITDA Margin History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Margin(%) -34.70-17.30-30.27-56.94-32.73

What is the latest Core EBITDA Margin ratio of KREBS BIOCHEMICALS & INDUSTRIES ?

The latest Core EBITDA Margin ratio of KREBS BIOCHEMICALS & INDUSTRIES is -34.70 based on Mar2025 Standalone results.
Year Core EBITDA Margin
Mar2025-34.70
Mar2024-17.30
Mar2023-30.27
Mar2022-56.94
Mar2021-32.73

How is Core EBITDA Margin of KREBS BIOCHEMICALS & INDUSTRIES Trending?

Years Core EBITDA Margin % Change
Mar2025 -34.7
Negative
Mar2024 -17.3
Negative
Mar2023 -30.27
Negative
Mar2022 -56.94
Negative
Mar2021 -32.73 -

Other Financial Ratios of KREBS BIOCHEMICALS & INDUSTRIES


Compare Core EBITDA Margin ratio of peers of KREBS BIOCHEMICALS & INDUSTRIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KREBS BIOCHEMICALS & INDUSTRIES ₹146.6 Cr 1.4% -6% -15.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,034.0 Cr 0.9% 5.3% 1.8% Stock Analytics
DIVIS LABORATORIES ₹169,211.0 Cr -2.3% -3.3% 12.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹124,875.0 Cr -3.3% 2.8% 19.7% Stock Analytics
CIPLA ₹122,082.0 Cr -1.6% -9.2% 4.4% Stock Analytics
DR REDDYS LABORATORIES ₹103,873.0 Cr NA -3.5% 4.6% Stock Analytics


KREBS BIOCHEMICALS & INDUSTRIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
KREBS BIOCHEMICALS & INDUSTRIES

1.4%

-6%

-15.9%

SENSEX

0.8%

1%

9.9%


You may also like the below Video Courses